Loading…
FormFactor, Inc.
🏹 Trader: | BRS 60 Forming View all →
$8.9B
Market Cap
84.1
P/E
1.25
PEG
7.1%
ROCE
5.5%
ROE
0.03
D/E
8.0%
OPM
-28.1%
% from 52W High
96
α RS
🔍 FORM is showing a sector-leadership setup because Sector RRG has Technology in the Leading quadrant with the trail still strengthening, RS Rating is 96 (top decile vs market), and fortress_balance preset's Backtest win rate is 53% over 90 days. Net: Broad signal stack, not a recommendation. ? RRG RS Rating Backtest
Sources
Technology in Leading quadrant · RS Rating 96 · Backtest win rate 53%
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for FORM including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

FormFactor, Inc. designs, manufactures, and sells probe cards, analytical probes, probe stations, thermal systems, cryogenic systems, and related services in the United States, South Korea, Taiwan, China, Japan, Singapore, Europe, Malaysia, and internationally. The company operates in two segments: Probe Cards and Systems segments. The company provides probe cards to test various semiconductor device types, including systems- on-chip products, such as graphics, central, digital processing units, and other custom application-specific processing units; mobile application processors, microprocessors, and microcontrollers; network devices, which include switches and network processing units; dynamic random-access memory; radio-frequency amplifiers and filters; antenna-in-package devices; analog and mixed-signal integrated circuits; image sensors; co-packaged optical integrated circuits; NAND flash memory; NOR flash memory; and quantum computer processor devices. It also offers analytical probes, which are used for device characterization, electrical simulation model development, failure analysis, and prototype design debugging; probe stations, a critical tool for the development of new generations of semiconductor and electro-optical processes and designs; and thermal subsystems, which include thermal chucks and other test systems used in probe stations and other applications for precise temperature management. In addition, the company provides cryogenic systems, which includes the manufacture of precision cryogenic instruments and semiconductor test and measurement systems; and services and support, including installation services. Further, it offers on-site probe card maintenance and service training, seminars, and telephone support services. It markets and sells its products through direct sales force, manufacturers’ representatives, and distributors. The company was incorporated in 1993 and is headquartered in Livermore, California.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding FORM
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 28.2K $2.7M 0.00% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific ~ Volatile 4 quarters Full tone analysis in Intelligence →
📊 MIXED FormFactor delivers record revenue $226M, 49% gross margin, achieves target model
Revenue & Profitability
Q1 2026 revenue was $226.1 million, above the midpoint of guidance. Non-GAAP gross margin was 49%, up 510 bps sequentially. Non-GAAP net income was $44.5 million ($0.56 per diluted share), compared to $36.6 million ($0.46) in Q4. GAAP net income was $20.4 million ($0.26), down from $23.2 million ($0.29) due to restructuring costs. Q2 2026 revenue is guided to $240 million ±$5 million.
Outlook
Management sees strong demand driven by HBM, networking, and data center CPU applications for AI inference. The DRAM environment remains supply-constrained, with customers shifting between HBM and DDR. Tariffs remain a headwind (~140 bps in Q2 guide), though recent transition to lower Section 232 tariffs provided some relief. Capacity constraints exist until the Farmers Branch site ramps, but the company expects continued sequential growth.
Growth Drivers
Key growth levers include: (1) HBM probe cards reaching another record with a second customer adopting SmartMatrix for HBM4 at-speed test; (2) Foundry & Logic growth from networking, data center CPU probe cards for AI inference, and upcoming GPU production qualification at the world's largest foundry; (3) CPO revenue expected at the high end of $10-20 million in 2026, driven by TRITON system ramp; (4) custom ASIC design wins with hyperscalers.
Balance Sheet & CapEx
Cash capital expenditure for Farmers Branch is expected to be $140-170 million in 2026, with pre-production ramp costs of $20-25 million in G&A. Incentives include about $24 million in cash grants for capital expenditures. The site is on track to come online later this year and ramp over 2027. In Q1, the company did not repurchase shares, prioritizing cash for expansion; $70.9 million remains under the buyback authorisation.
Margins
Non-GAAP gross margins improved 1,000 bps over the last three quarters to 49% in Q1, and Q2 is guided to 49.5% ±150 bps. The improvement came from operational effectiveness (restructuring, yield improvements, cycle time reductions) and tariff relief. About half of the Q1 overperformance (200 bps) was durable (restructuring savings and lower tariffs), and half was transitory timing items. Future gains are expected at a more moderate pace.
Key Risks
Risks flagged include tariffs (IEEPA-based tariffs paid may be refundable $9-11 million pending Supreme Court ruling), capacity constraints limiting revenue, macroeconomic and geopolitical conditions, and shifts in customer mix between HBM and DDR. In Q&A, analysts noted production ceiling until Farmers Branch ramps, and management acknowledged visibility remains challenging with lead times often shorter than a quarter.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-29
Record Q2 results with revenue up 14% sequentially and non-GAAP gross margin at 53.3%. Growth driven by HPC, advanced packaging, and strong CPO adoption; Q3 guidance points to continued momentum and Farmers Branch ramping in Q4.
Q1 2026 Q1 2026 2026-04-29
Record Q1 2026 revenue and gross margin exceeded guidance, driven by strong demand in HBM, networking, and operational improvements. Q2 outlook calls for further records, with Farmers Branch expansion set to support future growth and margin gains.
Q4 2025 Q4 2025 2026-02-04
Record Q4 and annual revenue were achieved, with gross margin and EPS exceeding guidance. Strong demand in DRAM, HBM, and data center applications is driving growth, while operational improvements and capacity expansion support further margin gains. Farmers Branch ramp and Keystone Photonics acquisition position the company for continued leadership.
Q3 2025 Q3 2025 2025-10-29
Q3 revenue, gross margin, and EPS surpassed guidance, with further sequential gains expected in Q4. DRAM/HBM led growth, while cost reduction and structural initiatives are driving margin improvement toward the 47% target. Investments in new capacity and technology support long-term growth.
Q2 2025 Q2 2025 2025-07-30
Q2 revenue exceeded guidance, driven by strong probe card demand, but gross margin was pressured by product mix and ramp-up costs. Strategic investments in capacity and technology position the company for growth in advanced packaging and AI markets, with Q3 revenue and margin expected to improve slightly.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.